UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Dedicated financial hardship screening adds value to routine distress screening among gynecologic cancer patients

Gynecologic oncology, 2024-04, Vol.183, p.53-60

2024

Volltextzugriff (PDF)

High-intermediate risk endometrial cancer: moving toward a molecularly based risk assessment profile

International journal of clinical oncology, 2022-02, Vol.27 (2), p.323-331

2022

Volltextzugriff (PDF)

Prehabilitation for medically frail patients undergoing surgery for epithelial ovarian cancer: a cost-effectiveness analysis

Journal of Gynecologic Oncology, 2021, 32(6), , pp.1-11

2021

Volltextzugriff (PDF)

Assessing Preclinical Research Models for Immunotherapy for Gynecologic Malignancies

Cancers, 2021-04, Vol.13 (7), p.1694

2021

Volltextzugriff (PDF)

Treatment of Cervical Cancer Complicated by Advanced Pelvic Organ Prolapse: A Case Report

Urogynecology, 2024-03, Vol.30 (3), p.309-313

2024

Volltextzugriff (PDF)

Identifying a molecular profile to predict the risk of recurrence in high‐intermediate risk endometrial cancer

Cancer medicine (Malden, MA), 2021-11, Vol.10 (22), p.8238-8250

2021

Volltextzugriff (PDF)

Identity-related experiences of Asian American trainees in gynecologic oncology

Gynecologic oncology reports, 2022-12, Vol.44, p.101097-101097, Article 101097

2022

Volltextzugriff (PDF)

Gynecologic oncology patients are ready for telemedicine in routine care: results from a pre-COVID survey

Gynecologic oncology, 2021-08, Vol.162, p.S168-S168

2021

Volltextzugriff (PDF)

Let's make a deal: Trainee and early graduate gynecologic oncologists are uncomfortable with productivity negotiations and contract negotiation (056)

Gynecologic oncology, 2023-09, Vol.176, p.S47-S48

2023

Volltextzugriff (PDF)

Black and Hispanic women are less likely than white women to receive guideline-concordant endometrial cancer treatment

American journal of obstetrics and gynecology, 2020-09, Vol.223 (3), p.398.e1-398.e18

2020

Volltextzugriff (PDF)

Assessing the rate of identification of financial hardship action items and completion of referrals for care (492)

Gynecologic oncology, 2022-08, Vol.166, p.S243-S244

2022

Volltextzugriff (PDF)

Comparing financial hardship (FH) assessment tools among gynecologic cancer patients (491)

Gynecologic oncology, 2022-08, Vol.166, p.S243

2022

Volltextzugriff (PDF)

Single-arm phase II trial of carboplatin and mirvetuximab soravtansine as neoadjuvant chemotherapy (NACT) for advanced- stage ovarian, fallopian tube or primary peritoneal cancer (EOC) who are folate receptor α positive (NCT04606914) (578)

Gynecologic oncology, 2022-08, Vol.166, p.S281

2022

Volltextzugriff (PDF)

Perceptions of barriers to patient financial hardship screening differ by provider role within gynecologic oncology outpatient care

Journal of clinical oncology, 2021-10, Vol.39 (28_suppl), p.317-317

2021

Volltextzugriff (PDF)

Vulvar Edema as Presenting Complication of Simultaneous Pancreas-Kidney Transplantation With Bladder Drainage

Journal of lower genital tract disease, 2019-01, Vol.23 (1), p.82-83

2019

Volltextzugriff (PDF)

Impact of BMI on immunotherapy outcomes in patients with advanced or recurrent endometrial cancer (1316)

Gynecologic oncology, 2023-09, Vol.176, p.S193-S194

2023

Volltextzugriff (PDF)

What are we worth?: The complexity of payment structures to measure and value work in gynecologic oncology (042)

Gynecologic oncology, 2023-09, Vol.176, p.S36-S37

2023

Volltextzugriff (PDF)

Guideline-concordant treatment is associated with improved survival among women with non-endometrioid endometrial cancer

Gynecologic oncology, 2020-06, Vol.157 (3), p.716-722

2020

Volltextzugriff (PDF)

Abstract A134: Minority women with non-endometrioid endometrial cancer are not less likely to receive guideline-concordant treatment than White women

Cancer epidemiology, biomarkers & prevention, 2020-06, Vol.29 (6_Supplement_2), p.A134-A134

2020

Volltextzugriff (PDF)

Peri-operative cardiac events in patient undergoing surgery for gynecologic malignancies are associated with long-term cardiovascular outcomes (489)

Gynecologic oncology, 2022-08, Vol.166, p.S242-S243

2022

Volltextzugriff (PDF)

Trends in cardiology follow-up and long-term care for patients who experienced cardiac events after surgery for gynecologic malignancies (490)

Gynecologic oncology, 2022-08, Vol.166, p.S243

2022

Volltextzugriff (PDF)

Missing the target: The oncology care model treatment pricing scheme is prohibitively reductive for gynecologic malignancies

Gynecologic oncology, 2022-04, Vol.165 (1), p.11-13

2022

Volltextzugriff (PDF)

Modification of intrinsic ovarian cancer tumor factors by Wnt-pathway agents influences macrophage recruitment and activity

Journal of clinical oncology, 2021-05, Vol.39 (15_suppl), p.e14514-e14514

2021

Volltextzugriff (PDF)

Towards a ‘hot’ tumor phenotype: DKN-01 sensitizes the tumor micro-environment via pro-immune cell cytokine release in vitro and ex vivo

Gynecologic oncology, 2021-08, Vol.162, p.S12-S12

2021

Volltextzugriff (PDF)

Whole exome sequencing provides loss of heterozygosity (LoH) data comparable to that of whole genome sequencing (171)

Gynecologic oncology, 2022-08, Vol.166, p.S100

2022

Volltextzugriff (PDF)

1 – 25 von 33

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(33)
Mit Volltextzugriff
(30)

Publikationsform

Artikel
(33)

Sprache

Englisch
(32)
Koreanisch
(1)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Dedicated financial hardship screening adds value to routine distress screening among gynecologic cancer patients

High-intermediate risk endometrial cancer: moving toward a molecularly based risk assessment profile

Prehabilitation for medically frail patients undergoing surgery for epithelial ovarian cancer: a cost-effectiveness analysis

Assessing Preclinical Research Models for Immunotherapy for Gynecologic Malignancies

Treatment of Cervical Cancer Complicated by Advanced Pelvic Organ Prolapse: A Case Report

Identifying a molecular profile to predict the risk of recurrence in high‐intermediate risk endometrial cancer

Identity-related experiences of Asian American trainees in gynecologic oncology

Gynecologic oncology patients are ready for telemedicine in routine care: results from a pre-COVID survey

Let's make a deal: Trainee and early graduate gynecologic oncologists are uncomfortable with productivity negotiations and contract negotiation (056)

Black and Hispanic women are less likely than white women to receive guideline-concordant endometrial cancer treatment

Assessing the rate of identification of financial hardship action items and completion of referrals for care (492)

Comparing financial hardship (FH) assessment tools among gynecologic cancer patients (491)

Single-arm phase II trial of carboplatin and mirvetuximab soravtansine as neoadjuvant chemotherapy (NACT) for advanced- stage ovarian, fallopian tube or primary peritoneal cancer (EOC) who are folate receptor α positive (NCT04606914) (578)

Perceptions of barriers to patient financial hardship screening differ by provider role within gynecologic oncology outpatient care

Vulvar Edema as Presenting Complication of Simultaneous Pancreas-Kidney Transplantation With Bladder Drainage

Impact of BMI on immunotherapy outcomes in patients with advanced or recurrent endometrial cancer (1316)

What are we worth?: The complexity of payment structures to measure and value work in gynecologic oncology (042)

Guideline-concordant treatment is associated with improved survival among women with non-endometrioid endometrial cancer

Abstract A134: Minority women with non-endometrioid endometrial cancer are not less likely to receive guideline-concordant treatment than White women

Peri-operative cardiac events in patient undergoing surgery for gynecologic malignancies are associated with long-term cardiovascular outcomes (489)

Trends in cardiology follow-up and long-term care for patients who experienced cardiac events after surgery for gynecologic malignancies (490)

Missing the target: The oncology care model treatment pricing scheme is prohibitively reductive for gynecologic malignancies

Modification of intrinsic ovarian cancer tumor factors by Wnt-pathway agents influences macrophage recruitment and activity

Towards a ‘hot’ tumor phenotype: DKN-01 sensitizes the tumor micro-environment via pro-immune cell cytokine release in vitro and ex vivo

Whole exome sequencing provides loss of heterozygosity (LoH) data comparable to that of whole genome sequencing (171)

Suchergebnisse filtern